Literature DB >> 32679527

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Anjali Verma1, Rajesh Rajput2, Surender Verma3, Vikas K B Balania2, Babita Jangra4.   

Abstract

BACKGROUND AND AIMS: COVID 19 is a novel pandemic affecting globally. Although no reliable data suggests that patients of well controlled Type 1 Diabetes Mellitus (T1DM) being at increased risk of becoming severely ill with SARS-CoV2, but lockdown may impact patients with T1DM requiring regular medications and follow up. Hence this study was planned to see the impact of lockdown on glycemic control in patients with T1DM.
METHODS: A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered on follow up within 15 days after lockdown. Data regarding hypoglycemic and hyperglycemic episodes, Diabetic ketoacidosis (DKA), insulin dose missed, regular glucose monitoring, dietary compliance, physical activity, hospitalization during the phase of lockdown was taken. Average blood glucose and HbA1C of lockdown phase was compared with the readings of prelockdown phase.
RESULTS: Out of 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, glucose monitoring not done routinely in 36.5% and 17.4% were not diet compliant during lockdown. Average blood glucose during lockdown phase was 276.9 ± 64.7 mg/dl as compared to 212.3 ± 57.9 mg/dl during prelockdown phase. Mean HbA1c value of lockdown (10 ± 1.5%) which was much higher that of pre lockdown (8.8 ± 1.3%) and the difference was statistically significant (p < 0.05).
CONCLUSION: Glycemic control of T1DM patients has worsened mainly due to non availability of insulin/glucostrips during lockdown period. There is a need for preparedness in future so that complications can be minimised.
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID 19; Diabetes mellitus; Lockdown

Mesh:

Substances:

Year:  2020        PMID: 32679527      PMCID: PMC7357511          DOI: 10.1016/j.dsx.2020.07.016

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


Introduction

Coronavirus disease 2019 (COVID-19) has aroused public health concerns in recent days and has progressively spread globally [1]. Although there are reports suggesting high mortality in adults with diabetes [2,3], however none suggested that children and adults with Type 1 Diabetes Mellitus (T1DM) are more severely affected than those who don’t have diabetes. Nevertheless, the International Society for Pediatric and Adolescent Diabetes (ISPAD) has emphasized the continued attentiveness to standard diabetes care during this period to avoid the need for urgent care visits or hospitalization [4]. So as to hinder and limit the possible spread of COVID-19, Indian government has ordered a series of phased lockdowns in which medical services were limited to emergencies only. During lockdown people were forced to stay in their homes which has resulted in change in physical activity, dietary pattern and psychological status of the individuals. All of these can impact the glucose control in patients of diabetes especially T1DM who are on insulin therapy. Also the lockdown has impacted the availability of treatment facilities for patients of chronic disease like diabetes. Past studies have showed that during disasters individuals with diabetes had short-term and long-term impact on glycemic parameters owing to the lack of medical care, appropriate food and medications [[5], [6], [7]]. Some studies in past have shown increase in complications of diabetes [[8], [9], [10]] whereas others have shown increase in elevation of HbA1c post disasters [11,12]. Although impact of COVID 19 on general health has been reported in various studies [[1], [2], [3]], there is paucity of literature on the impact of lockdown on management of patients of chronic illness like diabetes and no study has been reported from India till date. Hence this study was planned to see its impact on glycemic control of Type 1 Diabetes which will help us to be prepared about future disasters or pandemics.

Material and methods

This observational study was planned in a tertiary care teaching hospital and patients with T1DM who were on regular follow up in Endocrinology Outpatient department (OPD) were enrolled in the study. The first case of COVID-19 pandemic in India was reported on 30 January 2020 possibly originating from China. So as to prevent its spread, India has imposed lockdown in phased manner starting from 25th March till 30th May and thereafter started unlocking [13]. Local transport and interdistrict/interstate communication was strictly prohibited during the entire period. Hence we planned this study from 25th March till 31st May 2020 in which no diabetes specific specialty clinic was functional and only emergency services were going on in the state. However, primary care was available at a variety of community clinics with fragmented health care services. 52 consecutive patients who visited after lockdown and had given the consent were included in the study. The demographic details as well as their contact numbers of enrolled patients were taken from their databases in the endocrine OPD. Demographic details in form of age, sex, residence, source of family income, socioeconomic status using Modified Kuppuswamy scale updated for year 2020 were taken [14]. Details about type of insulin, its administration and associated diseases were also noted. They were telephonically called at the end of lockdown period and asked to report within 15 days after end of lockdown i.e. 30 May 2020. A structured questionnaire was administered to all the enrolled patients. Frequency of blood glucose readings falling in hypo and hyperglycemic range were noted from their daily blood glucose monitoring charts. Blood glucose levels ≤70 mg/dl and ≥180 mg/dl were considered as hypoglycemic and hyperglycemic episodes respectively. Data regarding episodes of DKA, insulin dose missed, regular blood glucose monitoring and any hospitalization during the period was recorded. Details regarding dietary compliance, physical activity, any psychological issues during the period were taken by recall method. Details regarding unavailability of insulin/glucostrips in their region or other reasons for impaired glucose control were also noted. Average of 3 glucose measurements per day was recorded in patients who were doing regular self monitoring of blood glucose levels and their mean was calculated over the entire period of lockdown. Whereas, mean of all the available readings was taken in patients who were not regularly monitored. Data of average blood glucose levels during both prelockdown and lockdown and HbA1C of both pre and lockdown phase was collected and analysed with paired sample t tests.

Results

Out of 52 patients, 27 (51.9%) patients were in the age group of 1–10 years followed by 19 (36.6%) in 11–20 years and only 6 (11.5%) were more than 20 years of age. Mean age was 11.9 years and male to female ratio was 0.7:1. Maximum and minimum age of enrolled patients were twenty three years and one and half year respectively. Associated celiac disease was present in 5 patients and hypothyroidism in 2 patients. Among 5 celiac patients, 2 children were not compliant with gluten free diet during lockdown due to non availability of gluten free food. More patients were from rural background [39 (75%)] and mainly belonging to lower socioeconomic status [34 (65.4%)] (Table 1 ). Only 13 (25%) had family income from government jobs who were regularly getting salaries during whole lockdown.
Table 1

Showing demographic characteristics of patients with T1DM (n = 52).

Characteristicsn (%)
Age
1–10 years27 (51.9)
11–20 years19 (36.6)
21–30 years6 (11.5)
Sex
Male22 (42.3)
Female30 (57.6)
Background
Rural39 (75)
Urban13 (25)
Source of income in family
Government job13 (25)
Private job28 (53.8)
Self employed11 (21.2)
Socio economic status
Upper middle4 (7.6)
Lower middle14 (27)
Upper lower25 (48.1)
Lower9 (17.3)
Insulin administered by
Parents19 (37)
Self24 (44)
Both10 (19)
Insulin used
Long acting + short acting analogue32 (62)
Intermediate acting + Short acting insulin17 (32)
Premix insulin (30:70)3 (6)
Associated illness
Celiac disease5 (9.6)
Hypothyroidism2 (3.8)
Showing demographic characteristics of patients with T1DM (n = 52). Insulin doses were missed in 14 (26.9%) and blood glucose monitoring was not done in 20 (38.5%) and 9 (17.4%) were not compliant with the diet during lockdown. Some (36.5%) have decreased physical activity out of which mainly were adolescents and adults (Table 2 ).
Table 2

Showing impact of lockdown period on various parameters (n = 52).

Parametersn (%)
Insulin doses missed
Yes14 (26.9)
No38 (73.1)
Blood glucose record maintained
Yes32 (61.5)
No20 (38.5)
Dietary compliance
Yes43 (82.6)
No9 (17.4)
Physical activity
Increased a3 (5.7)
Decreased a19 (36.5)
Same as before30 (57.8)
Psychological issue
Normal25 (48.1)
Irritable5 (9.6)
Happy16 (30.8)
Depressed6 (11.5)

As compared to pre lockdown period.

Showing impact of lockdown period on various parameters (n = 52). As compared to pre lockdown period. 19 (36.5%) had hyperglycemic episodes, 4 (7.7%) out of them landed into DKA and were ultimately hospitalised (Table 3 ). Out of 19 patients having hyperglycemia, 8 patients were not getting insulin injections due to non availability during lockdown and 3 patients because of financial issues as their family income was from private jobs. Non COVID febrile illness has lead to hyperglycemia in 3 patients whereas in rest 5 cases cause couldn’t be ascertained. Out of 4 patients with DKA, 3 patients had missed insulin doses due to non availability whereas one patient has started homeopathic medication. Reasons of not monitoring blood glucose were non availability of glucostrips (13 out of 20), financial issues (3 out of 20) and in 4 patients cause was not known.
Table 3

Showing impact of lockdown period on parameters related to glycemic control (n = 52).

Parametersn (%)
No of patients having hyperglycemic episodes19 (36.5)
No of patients having hypoglycemic episodes8 (15.3)
No of patients with hospitalization6 (11.5)

DKA

4 (7.7)

Hypoglycemia

1 (1.9)

Non COVID febrile illness

1 (1.9)

DKA: Diabetic ketoacidosis.

Showing impact of lockdown period on parameters related to glycemic control (n = 52). DKA Hypoglycemia Non COVID febrile illness DKA: Diabetic ketoacidosis. 8 (15.3%) patients had hypoglycemic episodes and 1 of them was hospitalised (Table 3). Out of 8 patients with hypoglycemic episodes, 3 patients were in honeymoon phase, 2 children had decreased intake in a febrile illness and in 3 patients cause could not be found. Average blood glucose during lockdown phase was 276.9 ± 64.7 mg/dl and during prelockdown phase was 212.3 ± 57.9 mg/dl. Although average blood glucose in lockdown was higher than that of prelockdown but the difference was not statistically significant (p = 0.15). Mean HbA1c of prelockdown and lockdown phase was 8.8 ± 1.3% (73 mmol/mol) and10 ± 1.5% (86 mmol/mol) respectively and the difference was statistically significant (p < 0.001).

Discussion

This study was done to identify challenges of complete lockdown during COVID19 in T1DM patients considering the importance of continuity of care. A lot of patients had impaired glucose control during this period and the main reason was non availability of insulin/glucostrips. This was probably due to limited stock in rural and semi urban areas and restrictions in transportation during the lockdown period. Furthermore, disparities in health, related to socioeconomic status that existed before the disaster have been exacerbated as there are many parents with private jobs who are not earning during lockdown. Our study was in concordance with previous few studies carried out on the effect of natural calamities on diabetes in which similar problems were encountered [7,15]. Moreover, authors in a study after Hurricane in Florida also suggested that by knowing the prevalence of major chronic conditions, assessment of need of medications should be made earlier so that replacement medications may be obtained well in time [15,16]. Other reasons were poor dietary compliance and lack of physical activity noticed in few patients. During lockdown children were at home with their non diabetic peers and all family members leading to poor compliance to their dietary habits. In addition children particularly adolescents are having much longer screen time, irregular sleep patterns thus limiting their routine physical activity which is usually recommended to improve glycemic control. It is already known that breaks from school (e.g. holidays) or periods when there is increase of sedentary behaviour lead to harmful influence on the glycemic control [17]. Similar results were seen in a recent study which showed that there was increase in carbohydrate intake, decrease in exercise, decreased monitoring of blood glucose and widespread mental stress in patients with Type 2 Diabetes Mellitus during the lockdown [18]. A few children recently diagnosed with T1DM also had episodes of hypoglycemia as a result of honeymoon phase during which they were not able to visit hospitals to show their sugar monitoring charts. Others had febrile illness leading to decreased intake ultimately leading to hypoglycemia. Some of the patients had serious emergencies like DKA and hypoglycemia requiring hospitalisations. That may be because many first responders in form of primary health care workers have limited knowledge about the management of diabetes emergencies. Some previous studies have also recommended development of more educational resources for patients and health care providers about the specific needs of people with diabetes pre, during and post disaster [5,9,10]. Most of our patients remained playful and happy. Most of our patients were children and adolescents who were enjoying holidays due to lockdown and concept of joint families won’t lead to stress in our country. This was contrary to studies in Japan after major earthquakes which had demonstrated an increase in stress associated with poor glycemic control [19,20]. Our study has showed negative impact of lockdown on glycemic control. Average blood glucose was higher during the lockdown phase however this was not statistically significant as our study was involving mainly pediatric patients and some of them (15.3%) had multiple episodes of hypoglycemia whereas some patients were not able to do regular glucose monitoring. Difference of HbA1c in prelockdown and lockdown phase was highly significant as it indicates average glucose levels over a prolonged period of 3 months. Our results were in concordance with a recent systematic review of health effects of storms and floods which reported an increase in HbA1c levels and the number of evaluations for diabetic complications post events [21]. Another recent study by Ghosal et al. has also concluded that duration of lockdown in COVID 19 is directly proportional to the worsening of glycaemic control and diabetes-related complications [22]. However, a similar study in Italy in this COVID pandemic showed that glycemic control of T1DM in adolescents did not worsen during the restrictions due to close monitoring of children by parents, more regular timetable of meals and reduced stress levels caused by school and all after-school activities. It rather improved in those who continued physical activity during the quarantine. Another reason found was the continuation of the health care professional assistance through telemedicine and CGMS which was not there in our set up [23]. Few more studies in which data was collected by remote monitoring of glucose sensors showed no deleterious effect of lockdown on glycemic control [24,25]. In addition, the knowledge that diabetes worsens the outcomes of COVID-19 may have improved patients’ awareness and compliance to diabetes management [26] but maximum of these patients were adults whereas in our study maximum were children and adolescents. No of patients in previous reports were small. This is one of largest study on T1DM from developing countries with limited resources, different sociodemographic culture as compared to the western world. Telehealth or telephonic consultations for sick day management and routine diabetes care should be encouraged to prevent complications and to partly mitigate the problem of uncontrolled diabetes during such pandemics in future. Advances in technology such as downloading records from insulin pumps/CGMS and remote monitoring should be used whenever possible to optimize glucose control. A module on preparedness should be included in diabetes self-management education. Proper assessment of community requirement of insulin as well as glucostrips should be made in advance as a part of preparedness. The limitation of this study was that it is a single-centre study. However, we believe that this information is valuable for health care professionals caring for children and adolescents during the COVID-19 pandemics and offers real-life data for further research. Hence results of our study should be used to establish innovative management strategies for patients with T1DM by collect maintaining data registry in order to learn for future pandemics.

Conclusion

Our study has clearly demonstrated negative impact of a pandemic on glycemic control in T1DM, a chronic condition which needs regular attention. The factors responsible such as non availability of insulin/glucostrips, poor dietary compliance and decreased physical activity need to be taken into consideration in planning and addressing chronic health conditions in the future pandemics because if appropriate action is not taken, the increase in health care costs could be considerable.

Funding

None.

Compliance with ethical standards

Yes.

Authors contribution

AV: implemented the study, collected data and wrote manuscript; RR: generated idea, supervised data collection, contributed to writing of manuscript; SV, BJ: data compilation, analysis and provided inputs in manuscript; VB: helped in data collection.

Declaration of competing interest

None.
  51 in total

1.  Telemedicine During the COVID-19 Pandemic: A Paradigm Shift in Non-Communicable Disease Management? - A Cross-Sectional Survey from a Quaternary-Care Center in South India.

Authors:  Sisira Ullas; Manu Pradeep; Sandeep Surendran; Anjali Ravikumar; Anna Maria Bastine; Ayush Prasad; Aravind Mohan
Journal:  Patient Prefer Adherence       Date:  2021-12-08       Impact factor: 2.711

Review 2.  Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: a narrative review.

Authors:  Ginenus Fekadu; Firomsa Bekele; Tadesse Tolossa; Getahun Fetensa; Ebisa Turi; Motuma Getachew; Eba Abdisa; Lemessa Assefa; Melkamu Afeta; Waktole Demisew; Dinka Dugassa; Dereje Chala Diriba; Busha Gamachu Labata
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-06-15

3.  Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran.

Authors:  Samereh Abdoli; Monica S V M Silveira; Mehri Doosti-Irani; Paulo Fanti; Katherine Miller-Bains; Elizabeth João Pavin; Edimariz Buin Cardoso; Leila Rafiee Vardanjani; Kobra Noorian; Danielle Hessler
Journal:  Diabetol Metab Syndr       Date:  2021-06-11       Impact factor: 3.320

4.  Impact of COVID-19 on follow-up and medication adherence in patients with glaucoma in a tertiary eye care centre in south India.

Authors:  G N Subathra; Sharmila R Rajendrababu; Vijayalakshmi A Senthilkumar; Iswarya Mani; B Udayakumar
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

5.  Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study.

Authors:  Ester Yeoh; Soon Guan Tan; Ying Shan Lee; Hwee Huan Tan; Ying Yee Low; Su Chi Lim; Chee Fang Sum; Subramaniam Tavintharan; Hwee Lin Wee
Journal:  Int J Clin Pract       Date:  2021-05-21       Impact factor: 3.149

6.  Effect of COVID-19 on control of T1DM patients in Aseer region of Saudi Arabia.

Authors:  Mohammad Ahmad Awwad Alqahtani; Abdullah Othman Al Othman; Amal Mohammed Alqahtani; Abdullah Mohammed Ahmed AlQahtani; Fatimah Abdullah Mohammad Asiri; Alqahtani Mohammed Mesfer; Sahar Dahman Alshehri; Suliman H Al-Fifi
Journal:  J Family Med Prim Care       Date:  2021-04-29

7.  COVID-19 Precautionary Measures and Type 1 Diabetes Patients in Saudi Arabia.

Authors:  Abdullah Alguwaihes; Mohammed E Al-Sofiani; Ebtihal Alyusuf; Aeshah Almutairi; Eman Ibrahim; Sarah S Albunyan; Saad Alzahrani; Rana Hasanto; Anwar A Jammah
Journal:  Prim Care Diabetes       Date:  2021-07-15       Impact factor: 2.459

8.  COVID-19 pandemic: Effects of national lockdown on the state of health of patients with type 2 diabetes mellitus in a Moroccan population.

Authors:  Hamid Farhane; Majida Motrane; Fatima-Ezzahra Anaibar; Aïcha Motrane; Said Nassor Abeid; Nourdin Harich
Journal:  Prim Care Diabetes       Date:  2021-06-21       Impact factor: 2.459

9.  Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study.

Authors:  Yasmine Ibrahim Elhenawy; Khadiga Yehia Eltonbary
Journal:  Int J Diabetes Dev Ctries       Date:  2021-07-09

10.  Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies.

Authors:  Giovanni Antonio Silverii; Chiara Delli Poggi; Ilaria Dicembrini; Matteo Monami; Edoardo Mannucci
Journal:  Acta Diabetol       Date:  2021-06-22       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.